Microbial and Systemic Effects of SNAC-Enabled Oral Semaglutide Administration
February 20, 2026
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
N/A
Synonyms :
xininurad
Class :
Urate transporter inhibitor (URAT)
Brand Name :
N/A
Synonyms :
xininurad
Class :
Urate transporter inhibitor (URAT)
Dosage Forms & Strengths
It is a URAT inhibitor and is being investigated for the treatment in gout. it decreases the uric acid levels, which helps to prevent the production and deposition of crystals in gout attacks
It belongs to the URAT inhibitor class and under investigation of clinical trials for its indication in the management of gout
It also lowers the uric acid levels which helps in preventing the formation and deposition of crystals and reduces the frequency of gout attacks
Not determined
Refer to adult dosing
Actions and Spectrum
Xininurad inhibits the transport of urate URAT1 that regulates the reabsorption of uric acid in kidneys.
Frequency not defined
None
Black Box Warning
there is no black box warning
Contraindication/Caution:
there are no contraindications
Pregnancy/Lactation
Pregnancy consideration:
Pregnancy category: N/A
Lactation: Excretion into human milk is unknown
Pregnancy Categories:
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.
Category B: There were a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments
Category C: There was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: Adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence, these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology
not known
Pharmacodynamics
there is no sufficient data available
Pharmacokinetics
Limited information available on ADME.
Administration
The administration of xininurad is not known.
Patient information leaflet
Generic Name: xininurad
Why do we use xininurad?
Xininurad is under investigations for the effectiveness in lowering uric acid levels.
This can help to prevent the formation and deposition of these crystals, reducing the frequency and severity of gout attacks.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
